Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Scott Kathleen D., Director. Insider active across 2 companies, notably Dermata Therapeutics, Inc.. In total, 8 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €50k. History available since 7 April 2022. The latest transaction was filed on 20 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
Kathleen D. Scott is a Board Member at Dermata Therapeutics, Inc. She plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. Her experience in the industry allows her to provide valuable insights during board discussions.